Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2025-12-25 @ 3:08 PM
NCT ID:
NCT04009668
Pre Assignment Details:
Following consent, participants provided a urine sample to measure urinary monocyte chemoattractant protein-1 (uMCP-1) and urinary tissue inhibitor of metalloprotease-1 (uTIMP-1), two indicators of intra-renal tumor necrosis factor (TNF) pathway activation. Participants with present TNF activation were advanced to screening. Upon confirmation of eligibility, participants proceeded to the treatment phase.
Recruitment Details:
Recruitment Period: 2019-2023 Recruitment Sites: University of Michigan, Ann Arbor, MI; New York University Langone Health, New York, NY; Cleveland Clinic, Cleveland, OH; Levine Children's Hospital at Atrium Health, Charlotte, NC.
Study:
NCT04009668
Study Brief:
Results Section:
NCT04009668